HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcelo Passos Teivelis Selected Research

oxybutynin (Tavor)

2/2018Combination of topical agents and oxybutynin as a therapeutic modality for patients with both osmidrosis and hyperhidrosis.
8/2017Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure.
12/2014Long-term results of oxybutynin treatment for palmar hyperhidrosis.
11/2014Long-term results of oxybutynin use in treating facial hyperhidrosis.
11/2014Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
9/2014Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin.
7/2014Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis.
1/2014Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcelo Passos Teivelis Research Topics

Disease

14Hyperhidrosis
08/2021 - 01/2014
3Aneurysm (Aneurysms)
01/2022 - 05/2012
3Hypersensitivity (Allergy)
02/2017 - 08/2014
2Diabetes Mellitus
10/2022 - 08/2021
2Peripheral Arterial Disease
10/2022 - 08/2014
2Congenital Abnormalities (Deformity)
01/2022 - 01/2021
2Carotid Stenosis (Carotid Artery Stenosis)
10/2021 - 07/2020
2Venous Thromboembolism
02/2021 - 10/2017
2Hemorrhage
02/2021 - 10/2017
2Neoplasms (Cancer)
02/2021 - 10/2017
2Abdominal Aortic Aneurysm
01/2021 - 10/2016
2Aortic Aneurysm (Aneurysm, Aortic)
11/2020 - 02/2017
1Hypertension (High Blood Pressure)
08/2021
1Stroke (Strokes)
08/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2021
1Endoleak
11/2020
1Thrombosis (Thrombus)
10/2017
1Venous Insufficiency
11/2016
1Thrombophlebitis
10/2016
1Infections
10/2016
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
04/2016
1Renal Insufficiency (Renal Failure)
04/2015
1Ganglion Cysts (Ganglion)
11/2014
1Gallstones (Gallstone)
01/2007
1Morbid Obesity
01/2007

Drug/Important Bio-Agent (IBA)

8oxybutynin (Tavor)FDA LinkGeneric
02/2018 - 01/2014
3Carbon DioxideIBA
11/2020 - 04/2015
3IodineIBA
02/2017 - 04/2015
2CreatinineIBA
02/2017 - 08/2014
1RivaroxabanIBA
10/2017
1AnticoagulantsIBA
10/2017
1Anti-Bacterial Agents (Antibiotics)IBA
05/2012

Therapy/Procedure

9Sympathectomy (Sympathectomies)
08/2021 - 01/2014
3Endovascular Procedures
01/2022 - 08/2014
3Therapeutics
08/2021 - 09/2014
3Endovascular Aneurysm Repair
01/2021 - 10/2016
2Catheters
01/2022 - 01/2021
2Endarterectomy (Thromboendarterectomy)
10/2021 - 07/2020
2Contraindications
02/2021 - 04/2016
1Surgical Amputation (Amputations)
10/2022
1Vena Cava Filters (Inferior Vena Cava Filter)
02/2021
1Microbubbles
01/2021
1Radiofrequency Ablation
11/2016
1Device Removal (Removal, Device)
10/2016
1Embolectomy
04/2015
1Operative Surgical Procedures
11/2014
1Aftercare (After-Treatment)
01/2014
1Cholecystectomy
01/2007
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2007